HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-NOV-12 4HVD TITLE JAK3 KINASE DOMAIN IN COMPLEX WITH 2-CYCLOPROPYL-5H-PYRROLO[2,3- TITLE 2 B]PYRAZINE-7-CARBOXYLIC ACID ((S)-1,2,2-TRIMETHYL-PROPYL)-AMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 811-1124; COMPND 5 SYNONYM: JANUS KINASE 3, JAK-3, LEUKOCYTE JANUS KINASE, L-JAK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE-INHIBITOR COMPLEX, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.SHAO REVDAT 3 20-SEP-23 4HVD 1 REMARK SEQADV REVDAT 2 30-JAN-13 4HVD 1 JRNL REVDAT 1 16-JAN-13 4HVD 0 JRNL AUTH M.SOTH,J.C.HERMANN,C.YEE,M.ALAM,J.W.BARNETT,P.BERRY, JRNL AUTH 2 M.F.BROWNER,K.FRANK,S.FRAUCHIGER,S.HARRIS,Y.HE, JRNL AUTH 3 M.HEKMAT-NEJAD,T.HENDRICKS,R.HENNINGSEN,R.HILGENKAMP,H.HO, JRNL AUTH 4 A.HOFFMAN,P.Y.HSU,D.Q.HU,A.ITANO,S.JAIME-FIGUEROA, JRNL AUTH 5 A.JAHANGIR,S.JIN,A.KUGLSTATTER,A.K.KUTACH,C.LIAO,S.LYNCH, JRNL AUTH 6 J.MENKE,L.NIU,V.PATEL,A.RAILKAR,D.ROY,A.SHAO,D.SHAW, JRNL AUTH 7 S.STEINER,Y.SUN,S.L.TAN,S.WANG,M.D.VU JRNL TITL 3-AMIDO PYRROLOPYRAZINE JAK KINASE INHIBITORS: DEVELOPMENT JRNL TITL 2 OF A JAK3 VS JAK1 SELECTIVE INHIBITOR AND EVALUATION IN JRNL TITL 3 CELLULAR AND IN VIVO MODELS. JRNL REF J.MED.CHEM. V. 56 345 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23214979 JRNL DOI 10.1021/JM301646K REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 82.7 REMARK 3 NUMBER OF REFLECTIONS : 21755 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1167 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 323 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 17.04 REMARK 3 BIN R VALUE (WORKING SET) : 0.2970 REMARK 3 BIN FREE R VALUE SET COUNT : 16 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2215 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 131 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.46000 REMARK 3 B22 (A**2) : -0.25000 REMARK 3 B33 (A**2) : -1.21000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.197 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.172 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.022 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2304 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3119 ; 0.976 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 273 ; 4.751 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;33.894 ;22.804 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;14.544 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;16.650 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 330 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1777 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 992 ; 0.178 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1563 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 147 ; 0.123 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 32 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.112 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1429 ; 0.561 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2219 ; 0.992 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1007 ; 1.230 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 897 ; 2.028 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1301 A 1431 REMARK 3 RESIDUE RANGE : A 1201 A 1202 REMARK 3 RESIDUE RANGE : A 815 A 1101 REMARK 3 ORIGIN FOR THE GROUP (A): 3.2617 -13.6160 -14.7465 REMARK 3 T TENSOR REMARK 3 T11: -0.0173 T22: -0.0388 REMARK 3 T33: -0.0048 T12: 0.0155 REMARK 3 T13: 0.0074 T23: 0.0220 REMARK 3 L TENSOR REMARK 3 L11: 0.3565 L22: 0.3347 REMARK 3 L33: 0.9277 L12: -0.0566 REMARK 3 L13: -0.1474 L23: 0.3679 REMARK 3 S TENSOR REMARK 3 S11: 0.0337 S12: 0.0154 S13: 0.0353 REMARK 3 S21: -0.0598 S22: -0.0307 S23: -0.0137 REMARK 3 S31: 0.0008 S32: 0.0178 S33: -0.0030 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HVD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000075967. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97929 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21755 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 44.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.7 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05000 REMARK 200 FOR THE DATA SET : 26.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 17.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.26300 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1YVJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG3350, 0.1M MES, 0.2M MGCL, PH REMARK 280 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.40800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.69600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.70800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.69600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.40800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.70800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 811 REMARK 465 GLN A 812 REMARK 465 ASP A 813 REMARK 465 PRO A 814 REMARK 465 GLY A 892 REMARK 465 PRO A 893 REMARK 465 GLY A 894 REMARK 465 ARG A 895 REMARK 465 GLN A 896 REMARK 465 SER A 897 REMARK 465 GLY A 1039 REMARK 465 SER A 1040 REMARK 465 GLU A 1041 REMARK 465 ARG A 1042 REMARK 465 ASP A 1043 REMARK 465 SER A 1102 REMARK 465 ARG A 1103 REMARK 465 GLY A 1104 REMARK 465 CYS A 1105 REMARK 465 GLU A 1106 REMARK 465 THR A 1107 REMARK 465 HIS A 1108 REMARK 465 ALA A 1109 REMARK 465 PHE A 1110 REMARK 465 THR A 1111 REMARK 465 ALA A 1112 REMARK 465 HIS A 1113 REMARK 465 PRO A 1114 REMARK 465 GLU A 1115 REMARK 465 GLY A 1116 REMARK 465 LYS A 1117 REMARK 465 HIS A 1118 REMARK 465 HIS A 1119 REMARK 465 SER A 1120 REMARK 465 LEU A 1121 REMARK 465 SER A 1122 REMARK 465 PHE A 1123 REMARK 465 SER A 1124 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 832 -106.53 63.31 REMARK 500 ARG A 948 -13.80 83.01 REMARK 500 ASP A 949 40.00 -141.37 REMARK 500 ALA A 966 -166.42 -128.55 REMARK 500 ASP A 967 76.56 58.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHU A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 933 A 1202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HVG RELATED DB: PDB REMARK 900 RELATED ID: 4HVH RELATED DB: PDB REMARK 900 RELATED ID: 4HVI RELATED DB: PDB DBREF 4HVD A 811 1124 UNP P52333 JAK3_HUMAN 811 1124 SEQADV 4HVD SER A 1040 UNP P52333 CYS 1040 ENGINEERED MUTATION SEQADV 4HVD SER A 1048 UNP P52333 CYS 1048 ENGINEERED MUTATION SEQRES 1 A 314 CYS GLN ASP PRO THR ILE PHE GLU GLU ARG HIS LEU LYS SEQRES 2 A 314 TYR ILE SER GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 3 A 314 GLU LEU CYS ARG TYR ASP PRO LEU GLY ASP ASN THR GLY SEQRES 4 A 314 ALA LEU VAL ALA VAL LYS GLN LEU GLN HIS SER GLY PRO SEQRES 5 A 314 ASP GLN GLN ARG ASP PHE GLN ARG GLU ILE GLN ILE LEU SEQRES 6 A 314 LYS ALA LEU HIS SER ASP PHE ILE VAL LYS TYR ARG GLY SEQRES 7 A 314 VAL SER TYR GLY PRO GLY ARG GLN SER LEU ARG LEU VAL SEQRES 8 A 314 MET GLU TYR LEU PRO SER GLY CYS LEU ARG ASP PHE LEU SEQRES 9 A 314 GLN ARG HIS ARG ALA ARG LEU ASP ALA SER ARG LEU LEU SEQRES 10 A 314 LEU TYR SER SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 11 A 314 GLY SER ARG ARG CYS VAL HIS ARG ASP LEU ALA ALA ARG SEQRES 12 A 314 ASN ILE LEU VAL GLU SER GLU ALA HIS VAL LYS ILE ALA SEQRES 13 A 314 ASP PHE GLY LEU ALA LYS LEU LEU PRO LEU ASP LYS ASP SEQRES 14 A 314 TYR TYR VAL VAL ARG GLU PRO GLY GLN SER PRO ILE PHE SEQRES 15 A 314 TRP TYR ALA PRO GLU SER LEU SER ASP ASN ILE PHE SER SEQRES 16 A 314 ARG GLN SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 17 A 314 GLU LEU PHE THR TYR CYS ASP LYS SER CYS SER PRO SER SEQRES 18 A 314 ALA GLU PHE LEU ARG MET MET GLY SER GLU ARG ASP VAL SEQRES 19 A 314 PRO ALA LEU SER ARG LEU LEU GLU LEU LEU GLU GLU GLY SEQRES 20 A 314 GLN ARG LEU PRO ALA PRO PRO ALA CYS PRO ALA GLU VAL SEQRES 21 A 314 HIS GLU LEU MET LYS LEU CYS TRP ALA PRO SER PRO GLN SEQRES 22 A 314 ASP ARG PRO SER PHE SER ALA LEU GLY PRO GLN LEU ASP SEQRES 23 A 314 MET LEU TRP SER GLY SER ARG GLY CYS GLU THR HIS ALA SEQRES 24 A 314 PHE THR ALA HIS PRO GLU GLY LYS HIS HIS SER LEU SER SEQRES 25 A 314 PHE SER HET PHU A1201 10 HET 933 A1202 21 HETNAM PHU 1-PHENYLUREA HETNAM 933 2-CYCLOPROPYL-N-[(2S)-3,3-DIMETHYLBUTAN-2-YL]-5H- HETNAM 2 933 PYRROLO[2,3-B]PYRAZINE-7-CARBOXAMIDE HETSYN PHU PHENYLUREA FORMUL 2 PHU C7 H8 N2 O FORMUL 3 933 C16 H22 N4 O FORMUL 4 HOH *131(H2 O) HELIX 1 1 GLU A 818 ARG A 820 5 3 HELIX 2 2 GLY A 861 ALA A 877 1 17 HELIX 3 3 CYS A 909 ARG A 918 1 10 HELIX 4 4 ALA A 919 LEU A 921 5 3 HELIX 5 5 ASP A 922 ARG A 943 1 22 HELIX 6 6 ALA A 951 ARG A 953 5 3 HELIX 7 7 PRO A 990 TYR A 994 5 5 HELIX 8 8 ALA A 995 ASN A 1002 1 8 HELIX 9 9 ARG A 1006 THR A 1022 1 17 HELIX 10 10 ASP A 1025 CYS A 1028 5 4 HELIX 11 11 SER A 1029 MET A 1038 1 10 HELIX 12 12 PRO A 1045 GLU A 1056 1 12 HELIX 13 13 PRO A 1067 TRP A 1078 1 12 HELIX 14 14 SER A 1081 ARG A 1085 5 5 HELIX 15 15 SER A 1087 GLY A 1101 1 15 SHEET 1 A 5 LEU A 822 GLY A 831 0 SHEET 2 A 5 GLY A 834 TYR A 841 -1 O VAL A 836 N LEU A 828 SHEET 3 A 5 ALA A 850 LEU A 857 -1 O VAL A 854 N GLU A 837 SHEET 4 A 5 ARG A 899 GLU A 903 -1 O LEU A 900 N LYS A 855 SHEET 5 A 5 TYR A 886 SER A 890 -1 N ARG A 887 O VAL A 901 SHEET 1 B 2 CYS A 945 VAL A 946 0 SHEET 2 B 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 C 2 ILE A 955 SER A 959 0 SHEET 2 C 2 HIS A 962 ILE A 965 -1 O LYS A 964 N LEU A 956 SHEET 1 D 2 TYR A 980 VAL A 982 0 SHEET 2 D 2 ILE A1003 SER A1005 -1 O PHE A1004 N TYR A 981 SITE 1 AC1 6 TRP A1011 PRO A1030 ARG A1059 LEU A1060 SITE 2 AC1 6 TRP A1078 HOH A1338 SITE 1 AC2 9 LEU A 828 GLY A 829 ALA A 853 GLU A 903 SITE 2 AC2 9 TYR A 904 LEU A 905 ASN A 954 LEU A 956 SITE 3 AC2 9 HOH A1316 CRYST1 46.816 75.416 89.392 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021360 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013260 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011187 0.00000